Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| we were able to deliver stronger bottom-line and improved cash flow results based on our continued focus on our underlying cost structure |
| And it's just a better experience overall for our customer |
| our innovative technology-driven solutions combined with disciplined cost management allowed us to deliver solid results despite the continuing challenging economic backdrop impacting our core customer |
| However, adjusted EBITDA improved by $10 million and free cash flow by $8 million, compared to the prior year |
| This marks the fourth straight quarter of year-over-year adjusted EBITDA improvement and fifth straight quarter of year-over-year free cash flow improvement |
| So, not only are we seeing what David explained is, lower lead acquisition costs coming from SMP, but we're also able to drive additional sales through stores themselves without the additional marketing |
| We expect a good outcome |
| We actually had a record during this quarter and with the price increases we put in place on the whole aligner business, as well as what CarePlus can contribute in the back half of the year, we'll see higher ASPs associated with that |
| We are also maintaining our financial goals for the year as the cost changes we have put in place continue to drive us towards positive adjusted EBITDA in the third quarter of 2023 and positive free cash flow by the fourth quarter |
| Leveraging all the benefits of SMP together drives improved financial performance on top of our core business |
| SMP is showing signs of driving stronger marketing efficiencies through tangible benefits by reducing our cost per lead |
| Our free cash flows continued to consistently improve as we have progressed through the year and we just posted our fifth consecutive quarter of improving year-over-year free cash flow |
| on a year-to-date basis, our free cash flow has improved by over $43 million as our focus on rigorous financial discipline has improved our efficiency |
| This quarter represents our fourth consecutive quarter of reporting improving year-over-year adjusted EBITDA results, and as we are on track for a continued improvement and delivering positive adjusted EBITDA in the third quarter |
| for the full year, adjusted EBITDA has improved by $18 million, compared to the prior year |
| In addition, with the soft launch of our SmileMaker app, we are seeing significant improvements in cost per lead and cost per app download |
| With these improvements, we are continuing to drive lower customer acquisition costs for our legacy business |
| the fact that we keep a credit card on file and have a low monthly payment gives us the confidence that SmilePay will continue to perform well |
| in the current quarter, we improved adjusted EBITDA by $10 million and improved free cash flow by $8 million despite a $24 million year-over-year decline in revenue from the second quarter of 2022, compared to the current quarter |
| As David mentioned, for the last four consecutive quarters, we have improved the year-over-year EBITDA |
| We continue to have discussions with interested parties to improve our liquidity position by expanding our ABL facility, backed by our successful SmilePay Collateral, as well as other interested investors, who see the value in SDC as the leader in affordable teeth straightening, especially with the successful launch of our two key initiatives |
| This is a strong value proposition for our partner network by leveraging the sales efforts of SmileShops to drive CarePlus consumers to their practices and benefit from the full sales and marketing firepower of SDC |
| As I mentioned in my opening remarks, this marks the fourth straight quarter of year-over-year adjusted EBITDA improvement and fifth straight quarter of year-over-year free cash flow improvement |
| All of the above produced adjusted EBITDA of negative $14 million in the first quarter, which is a $10 million improvement over the second quarter of 2022 despite a $24 million decrease in revenue |
| That being said, again, I think we've been able to manage liquidity pretty well |
| And then I think, as we've also announced, we've got three [ph] positive EBITDA |
| Our SmilePay program is an important component to drive affordability with our customer base, and overall, the program has continued to perform well with our delinquency rates in Q2, consistent with historical levels |
| So either way, you get there, whether you increase conversion or you lower your lead costs, it improves your CAC |
| Feedback has been positive from dental practitioners as this provides a steady referral of CarePlus customers to drive additional revenue streams to the practice, but with the bulk of the sales process being completed by SmileShop team members |
| our second quarter net loss was $54 million, which is an $11 million improvement over the prior-year period |
| Statement |
|---|
| gross margin for the quarter was 71.6%, which was down from 72.5% in the first quarter |
| Our Q2 revenue of $102 million, decreased $24 million from the prior-year period |
| revenue for the second quarter was $102 million, which is a decrease of 15% sequentially and a decrease of 19% on a year-over-year basis |
| As far as how we break out the new initiatives and the sales associated with those, we effectively added in the new initiatives and then we actually reduced kind of the core guidance in the back half of the year |
| Although the second quarter top-line results followed our typical seasonal downward Q1 to Q2 revenue trends |
| in the back half, we had a very challenging fourth quarter last year |
| The new initiatives were somewhat delayed this year compared to the original expectations due to our continued focus on launching in a way that was best for our customers while meeting our efficiency goals |
| And so as you look at kind of Q3 and Q4, we did see a little bit of weakness |
| and Canada came in at negative $6 million and rest of world adjusted EBITDA was negative $8 million |
| So, we effectively took down our core guidance |
| Cash from operations for the second quarter was negative $18 million, while cash spent on investing for the quarter was negative $10 million |
| The lower gross margin rate was driven primarily by the deleveraging of fixed cost in our manufacturing process on lower sales |
| at the same time, challenges to the consumer spending and sustained high inflation continue to impact our overall expected demand in 2023 as to our core business |
| The sequential decline was within our guidance range and was driven by the typical seasonal trend coming off of the new Year -- new Year effect from Q1 |
| providing some details on the other revenue items, implicit price concessions were 10% of gross aligner revenue, down from 11% in the first quarter |
| And then from a G&A perspective, we've driven G&A down from last year, certainly Q1 was lower, Q2 was lower than that |
| It's been a long road, but worth the sacrifice as SMP and CarePlus begin to pay off |
| In other expenses, we recognized losses of $0.3 million, primarily due to unrealized foreign currency translation adjustments recorded in the quarter |
| Financing revenue, which is interest associated with our SmilePay program, came in at approximately $7 million, which is consistent with Q1 2023 and down approximately $2 million year-over-year due to the lower accounts receivable balance |
| As a result, these added costs, as well as the sales impact from a cautionary environment; offset the margin added for the new initiatives |
Please consider a small donation if you think this website provides you with relevant information